Total Payments
$11,371
2024 Payments
$583.52
Companies
20
Transactions
817
Medicare Patients
593
Medicare Billing
$45,709
Payment Breakdown by Category
Food & Beverage$11,058 (97.2%)
Education$313.39 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,058 | 813 | 97.2% |
| Education | $313.39 | 4 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,562 | 128 | $0 (2024) |
| Alkermes, Inc. | $1,417 | 62 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,389 | 118 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,248 | 140 | $0 (2021) |
| Vanda Pharmaceuticals Inc. | $1,009 | 60 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $939.01 | 66 | $0 (2024) |
| Allergan, Inc. | $895.43 | 40 | $0 (2020) |
| Indivior Inc. | $797.30 | 42 | $0 (2024) |
| Lundbeck LLC | $632.55 | 55 | $0 (2024) |
| ABBVIE INC. | $434.26 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $583.52 | 26 | Teva Pharmaceuticals USA, Inc. ($158.17) |
| 2023 | $432.13 | 24 | Janssen Pharmaceuticals, Inc ($110.02) |
| 2022 | $1,210 | 92 | Janssen Pharmaceuticals, Inc ($241.90) |
| 2021 | $2,045 | 166 | Janssen Pharmaceuticals, Inc ($317.41) |
| 2020 | $1,981 | 160 | Sunovion Pharmaceuticals Inc. ($319.90) |
| 2019 | $1,598 | 138 | Sunovion Pharmaceuticals Inc. ($273.25) |
| 2018 | $1,848 | 113 | Allergan Inc. ($438.70) |
| 2017 | $1,674 | 98 | Allergan Inc. ($322.49) |
All Payment Transactions
817 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $37.57 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $20.83 | General |
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: OUD | ||||||
| 10/08/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Neuroscience | ||||||
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $17.80 | General |
| 10/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.33 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: CNS | ||||||
| 09/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: PSYCHIATRY | ||||||
| 08/27/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.49 | General |
| 08/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Neurology | ||||||
| 08/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $0.41 | General |
| Category: Neurology | ||||||
| 08/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: SCHIZOPHRENIA | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: NEUROSCIENCE | ||||||
| 07/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Neuroscience | ||||||
| 05/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: CNS | ||||||
| 03/12/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Neurology | ||||||
| 02/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: PSYCHIATRY | ||||||
| 02/22/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: BH | ||||||
| 02/14/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Neuroscience | ||||||
| 02/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.56 | General |
| Category: PSYCHIATRY | ||||||
| 01/24/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: Neurology | ||||||
| 01/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 46 | 52 | $3,360 | $1,458 |
| 2022 | 1 | 113 | 258 | $16,434 | $8,144 |
| 2021 | 2 | 184 | 479 | $31,497 | $16,729 |
| 2020 | 2 | 250 | 583 | $38,328 | $19,378 |
Total Patients
593
Total Services
1,372
Medicare Billing
$45,709
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 52 | $3,360 | $1,458 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 258 | $16,434 | $8,144 | 49.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 164 | 459 | $29,661 | $15,757 | 53.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $1,837 | $971.48 | 52.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 206 | 528 | $34,119 | $17,364 | 50.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 23 | 34 | $2,197 | $1,023 | 46.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 21 | 21 | $2,011 | $991.28 | 49.3% |
About Dr. Patrick Horn, MD
Dr. Patrick Horn, MD is a Psychiatry healthcare provider based in Moore, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2008. The National Provider Identifier (NPI) number assigned to this provider is 1841450855.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Horn, MD has received a total of $11,371 in payments from pharmaceutical and medical device companies, with $583.52 received in 2024. These payments were reported across 817 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($11,058).
As a Medicare-enrolled provider, Horn has provided services to 593 Medicare beneficiaries, totaling 1,372 services with total Medicare billing of $45,709. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Moore, OK
- Active Since 06/12/2008
- Last Updated 01/11/2026
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1841450855
Products in Payments
- REXULTI (Drug) $1,407
- VRAYLAR (Drug) $1,330
- LATUDA (Drug) $1,248
- INVEGA SUSTENNA (Drug) $1,132
- ARISTADA (Drug) $896.08
- HETLIOZ (Drug) $610.55
- AUSTEDO (Drug) $563.94
- PERSERIS (Drug) $546.15
- ABILIFY MAINTENA (Drug) $534.56
- Aristada 441 mg (Drug) $441.12
- CAPLYTA (Drug) $399.77
- INVEGA TRINZA (Drug) $376.00
- Fanapt (Drug) $335.04
- SUBLOCADE (Drug) $251.15
- INGREZZA (Drug) $231.91
- NUEDEXTA (Drug) $207.24
- TRINTELLIX (Drug) $96.30
- UZEDY (Drug) $63.60
- FANAPT (Drug) $63.58
- VIVITROL (Drug) $61.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Moore
Rachel Dalthorp, Md, MD
Psychiatry — Payments: $114,015
Psychiatry $114,015
Maria Plata, Md, MD
Psychiatry — Payments: $553.16
Psychiatry $553.16
Danielle Sandbothe, Do, DO
Psychiatry — Payments: $43.23
Psychiatry $43.23
Clayton Morris, M.d, M.D
Psychiatry — Payments: $37.38
Psychiatry $37.38
Darius Noori, M.d, M.D
Psychiatry
Psychiatry
William Tankersley, Md, MD
Psychiatry
Psychiatry